FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034904085> ?p ?o ?g. }

• W2034904085 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCProteomic analysis of cellular signaling networks has strongly gained in importance in the field of cancer research and treatment. In particular, there is a focus on the activation status of growth factor receptor related signaling cascades represented by phosphoproteins, as key mediators of cellular signaling. For example, the inhibition of the EGF-receptor pathway has been widely integrated into clinical practice for different tumor entities, e.g. non small lung cancer and colorectal cancer. Although, predictive genetic markers of response to targeted therapy such as KRAS testing are already in use, heterogeneity in responses to treatment has been clinically observed. In order to understand this heterogeneity on the proteome level, the activation status of cell signaling proteins has to be analyzed. The in-depth analysis of isoform phosphorylation can potentially reveal significant biological differences in activation patterns and might result in predictive signatures.In this study, we differentially analyzed basal isoform phosphorylations of selected key proteins of two EGF-receptor downstream pathways, in four primary colorectal tumors and their corresponding metastases using the NanoPro1000 technology. Patient's biospecimen were collected according to standard operating procedures, ensuring a high quality of tissues characterized by ischemia times below 10 minutes, comprehensive clinical data and corresponding sets of body fluids. The detailed characterization of isoform phosphorylations was conducted using the recently introduced NanoPro1000 technology. This assay provides the separation of phospho protein isoforms by high-resolution isoelectric focusing (IEF) combined with a specific, antibody based detection. In addition to these data, the mutation status of selected, clinical relevant genes (KRAS, BRAF and PIK3CA) was determined in primary and metastatic tumor samples using Sanger sequencing. Among the analyzed primary tumors, there were two KRAS mutants, one BRAF mutant and one wild type tumor. Identical results were found in the matched metastasis.NanoPro1000 analysis revealed that isoform phosphorylation of ERK1/2, AKT and MEK1/2 differed among patients, as well as primary tumors and metastases. For example, ERK1 showed a tendency to be higher mono- and dual-phosphorylated in the primary tumors, whereas mono-phosphorylated ERK2 was elevated in metastases. However, a correlation to the mutation status was not found.These differences may explain the heterogeneity of individual responses to target anticancer treatment among patients, independent of their mutation status. Therefore, the NanoPro1000 technology can potentially be useful to identify predictive biomarker for the development of resistance to anti-EGF-receptor treatment and further improve personalized medicine.Citation Format: Florian T. Unger, Jana Krueger, Janina Schaller, Cordula Dede, Alexandra Samsen, Hartmut Juhl, Kerstin A. David. Comparison of ERK, AKT and MEK isoform phosphorylations between primary and corresponding metastatic colorectal carcinoma lesions using the NanoPro1000 technology. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2408. doi:10.1158/1538-7445.AM2013-2408" @default.
• W2034904085 created "2016-06-24" @default.
• W2034904085 creator A5000809939 @default.
• W2034904085 creator A5013722284 @default.
• W2034904085 creator A5032020884 @default.
• W2034904085 creator A5034709249 @default.
• W2034904085 creator A5044160974 @default.
• W2034904085 creator A5053310450 @default.
• W2034904085 creator A5055923367 @default.
• W2034904085 date "2013-04-15" @default.
• W2034904085 modified "2023-09-27" @default.
• W2034904085 title "Abstract 2408: Comparison of ERK, AKT and MEK isoform phosphorylations between primary and corresponding metastatic colorectal carcinoma lesions using the NanoPro1000 technology." @default.
• W2034904085 doi "https://doi.org/10.1158/1538-7445.am2013-2408" @default.
• W2034904085 hasPublicationYear "2013" @default.
• W2034904085 type Work @default.
• W2034904085 sameAs 2034904085 @default.
• W2034904085 citedByCount "0" @default.
• W2034904085 crossrefType "proceedings-article" @default.
• W2034904085 hasAuthorship W2034904085A5000809939 @default.
• W2034904085 hasAuthorship W2034904085A5013722284 @default.
• W2034904085 hasAuthorship W2034904085A5032020884 @default.
• W2034904085 hasAuthorship W2034904085A5034709249 @default.
• W2034904085 hasAuthorship W2034904085A5044160974 @default.
• W2034904085 hasAuthorship W2034904085A5053310450 @default.
• W2034904085 hasAuthorship W2034904085A5055923367 @default.
• W2034904085 hasConcept C104317684 @default.
• W2034904085 hasConcept C121608353 @default.
• W2034904085 hasConcept C126322002 @default.
• W2034904085 hasConcept C170493617 @default.
• W2034904085 hasConcept C2779438470 @default.
• W2034904085 hasConcept C2781187634 @default.
• W2034904085 hasConcept C502942594 @default.
• W2034904085 hasConcept C526805850 @default.
• W2034904085 hasConcept C53345823 @default.
• W2034904085 hasConcept C54355233 @default.
• W2034904085 hasConcept C57074206 @default.
• W2034904085 hasConcept C60644358 @default.
• W2034904085 hasConcept C62478195 @default.
• W2034904085 hasConcept C71924100 @default.
• W2034904085 hasConcept C75217442 @default.
• W2034904085 hasConcept C86554907 @default.
• W2034904085 hasConcept C86803240 @default.
• W2034904085 hasConcept C95444343 @default.
• W2034904085 hasConceptScore W2034904085C104317684 @default.
• W2034904085 hasConceptScore W2034904085C121608353 @default.
• W2034904085 hasConceptScore W2034904085C126322002 @default.
• W2034904085 hasConceptScore W2034904085C170493617 @default.
• W2034904085 hasConceptScore W2034904085C2779438470 @default.
• W2034904085 hasConceptScore W2034904085C2781187634 @default.
• W2034904085 hasConceptScore W2034904085C502942594 @default.
• W2034904085 hasConceptScore W2034904085C526805850 @default.
• W2034904085 hasConceptScore W2034904085C53345823 @default.
• W2034904085 hasConceptScore W2034904085C54355233 @default.
• W2034904085 hasConceptScore W2034904085C57074206 @default.
• W2034904085 hasConceptScore W2034904085C60644358 @default.
• W2034904085 hasConceptScore W2034904085C62478195 @default.
• W2034904085 hasConceptScore W2034904085C71924100 @default.
• W2034904085 hasConceptScore W2034904085C75217442 @default.
• W2034904085 hasConceptScore W2034904085C86554907 @default.
• W2034904085 hasConceptScore W2034904085C86803240 @default.
• W2034904085 hasConceptScore W2034904085C95444343 @default.
• W2034904085 hasLocation W20349040851 @default.
• W2034904085 hasOpenAccess W2034904085 @default.
• W2034904085 hasPrimaryLocation W20349040851 @default.
• W2034904085 hasRelatedWork W1610645793 @default.
• W2034904085 hasRelatedWork W1975747940 @default.
• W2034904085 hasRelatedWork W1982855119 @default.
• W2034904085 hasRelatedWork W2047046631 @default.
• W2034904085 hasRelatedWork W2056785598 @default.
• W2034904085 hasRelatedWork W2059386885 @default.
• W2034904085 hasRelatedWork W2076099688 @default.
• W2034904085 hasRelatedWork W2121886536 @default.
• W2034904085 hasRelatedWork W2135211151 @default.
• W2034904085 hasRelatedWork W2152493428 @default.
• W2034904085 hasRelatedWork W2317422085 @default.
• W2034904085 hasRelatedWork W2397568682 @default.
• W2034904085 hasRelatedWork W2487764949 @default.
• W2034904085 hasRelatedWork W2511809967 @default.
• W2034904085 hasRelatedWork W2607728961 @default.
• W2034904085 hasRelatedWork W2626740709 @default.
• W2034904085 hasRelatedWork W2785987183 @default.
• W2034904085 hasRelatedWork W2789350247 @default.
• W2034904085 hasRelatedWork W3085141404 @default.
• W2034904085 hasRelatedWork W3089446304 @default.
• W2034904085 isParatext "false" @default.
• W2034904085 isRetracted "false" @default.
• W2034904085 magId "2034904085" @default.
• W2034904085 workType "article" @default.